Renin–angiotensin system inhibition in COVID-19 patients:Friend or foe?

References (9)

1. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogen-esis. J Pathol 2004; 203: 631-7
2. Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tal-lant EA, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-con-verting enzyme 2. Circulation 2005; 111: 2605-10.3. Kuster GM, Pfister O, Burkard T, Zhou Q, Twerenbold R, Haaf P, et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J 2020; 41: 1801-3
3. Furuhashi M, Moniwa N, Mita T, Fuseya T, Ishimura S, Ohno K, et al. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor block-er. Am J Hypertens 2015; 28: 15-21
4. The European Society for Cardiology. ESC Guidance for the Diag-nosis and Management of CV Disease during the COVID-19 Pan-demic. Available online; URL: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance 6. de Vries AAF. Renin-angiotensin system inhibition in COVID-19 patients. Neth Heart J 2020: 1–6. doi: 10.1007/s12471-020-01439-5. Epub ahead of print 7. Alexandre J, Cracowski JL, Richard V, Bouhanick B; 'Drugs, COV-ID-19' working group of the French Society of Pharmacology, Ther-apeutics. Renin-angiotensin-aldosterone system and COVID-19 infection. Ann Endocrinol (Paris) 2020; 81: 63-7
5. Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey GH, Gramberg T, Pöhlmann S. Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble re-ceptor. Biochem Biophys Res Commun 2004; 319: 1216-21
6. Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol 2006; 6: 271-6
7. Eroğlu İ, Eroğlu BÇ, Uyaroğlu OA, Güven GS. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COV-ID-19 patients: Is the remedy here? Anatol J Cardiol 2020; 24: 19-20
8. Şenkal N, Meral R, Medetalibeyoğlu A, Konyaoğlu H, Köse M, Tükek T. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19. Ana-tol J Cardiol 2020; 24: 21-9
9. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects fro